George Morrow - Align Technology Independent Director
| ALGN Stock | USD 305.01 4.87 1.62% |
Director
Mr. George J. Morrow is Independent Director of the Company. Mr. Morrow has served as a director of Align since February 2006. From February 2011 until January 2013, Mr. Morrow served as a consultant to Amgen Inc., a global biotechnology company. From 2003 until his retirement in February 2011, he was the Executive Vice President, Global Commercial Operations at Amgen Inc., where he also served as Executive Vice President of Worldwide Sales and Marketing between 2001 and 2003. From 1992 to 2001, Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including President and Chief Executive Officer of Glaxo Wellcome Inc. He currently serves on the board of directors of Vical Incorporated, a company that researches and develops biopharmaceutical products, and Neurocrine Biosciences, a biotechnology company focused on neurologic, psychiatric and endocrine related disorders. He also served on the board of Safeway Inc., a food and drug retailer from May 2013 until February 2015 From April 2015 to June 2018, he served on the board of Otonomy, Inc., a clinicalstage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear since 2006.
| Age | 66 |
| Tenure | 18 years |
| Professional Marks | MBA |
| Address | 410 North Scottsdale Road, Tempe, AZ, United States, 85288 |
| Phone | 602 742 2000 |
| Web | https://www.aligntech.com |
George Morrow Latest Insider Activity
Tracking and analyzing the buying and selling activities of George Morrow against Align Technology stock is an integral part of due diligence when investing in Align Technology. George Morrow insider activity provides valuable insight into whether Align Technology is net buyers or sellers over its current business cycle. Note, Align Technology insiders must abide by specific rules, including filing SEC forms every time they buy or sell Align Technology'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
George Morrow over a month ago Disposition of 20000 shares by George Morrow of Neurocrine Biosciences at .79 subject to Rule 16b-3 |
Align Technology Management Efficiency
The company has return on total asset (ROA) of 0.0682 % which means that it generated a profit of $0.0682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1231 %, meaning that it created $0.1231 on every $100 dollars invested by stockholders. Align Technology's management efficiency ratios could be used to measure how well Align Technology manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Align Technology's Return On Tangible Assets are very stable compared to the past year. As of the 18th of April 2024, Return On Capital Employed is likely to grow to 0.17, while Return On Equity is likely to drop 0.09. At this time, Align Technology's Intangible Assets are very stable compared to the past year. As of the 18th of April 2024, Net Tangible Assets is likely to grow to about 3.7 B, while Deferred Long Term Asset Charges is likely to drop about 52.9 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Gary Ellis | Inspire Medical Systems | 64 | |
| Shawn McCormick | Inspire Medical Systems | 56 | |
| Jerry Griffin | Inspire Medical Systems | 76 | |
| Robert Pozen | Medtronic PLC | 71 | |
| Leslie Heisz | Edwards Lifesciences Corp | 60 | |
| Kieran Gallahue | Edwards Lifesciences Corp | 57 | |
| Richard Valencia | Tandem Diabetes Care | 56 | |
| Scott Donnelly | Medtronic PLC | 59 | |
| Steven Sobieski | Insulet | 57 | |
| Frederic Moll | Shockwave Medical | N/A | |
| Nilesh Jagatia | Inspire Medical Systems | 50 | |
| Eric Topol | DexCom Inc | 63 | |
| Michael Minogue | Insulet | 50 | |
| John Cardis | Edwards Lifesciences Corp | 73 | |
| William Link | Edwards Lifesciences Corp | 73 | |
| Kevin Sullivanhas | Penumbra | N/A | |
| Randall Hogan | Medtronic PLC | 64 | |
| Casey Tansey | Inspire Medical Systems | 63 | |
| Steven Loranger | Edwards Lifesciences Corp | 69 | |
| Sherilyn McCoy | Stryker | 62 | |
| Howard Greene | Tandem Diabetes Care | 75 | |
Management Performance
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0682 |
Align Technology Leadership Team
Elected by the shareholders, the Align Technology's board of directors comprises two types of representatives: Align Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Align. The board's role is to monitor Align Technology's management team and ensure that shareholders' interests are well served. Align Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Align Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Raphael Pascaud, Chief Marketing Portfolio and Bus. Devel. Officer | ||
| Sreelakshmi Kolli, Vice President - Information Technology | ||
| George Morrow, Independent Director | ||
| David White, CFO | ||
| Shirley Stacy, IR Contact Officer | ||
| Joseph Hogan, CEO and President and Director | ||
| Sian Roberts, Vice President and General Manager - of Canada | ||
| Joseph Lacob, Independent Director | ||
| Lynn Pendergrass, Vice President Managing Director - Americas Region | ||
| Jennifer Erfurth, Vice President - Global Human Resources | ||
| Emory Wright, Executive Operations | ||
| Simon Beard, Vice President Managing Director - EMEA | ||
| Kevin Dallas, Director | ||
| Gregory Santora, Independent Director | ||
| Zelko Relic, Vice President - Research and Development | ||
| Andrea Saia, Independent Director | ||
| Brad Jergenson, Vice President and General Manager - United States | ||
| Raj Pudipeddi, Senior Vice President Chief Marketing Officer | ||
| Susan Siegel, Independent Director | ||
| Warren Thaler, Independent Director | ||
| Markus Sebastian, Senior Vice President Managing Director, EMEA | ||
| Raymond Larkin, Independent Chairman of the Board | ||
| Vamsi Pudipeddi, Chief VP | ||
| Christopher Puco, Vice President - North American Sales | ||
| David Nagel, Independent Director | ||
| Jennifer OlsonWilk, Executive Success | ||
| John Morici, CFO Finance | ||
| Anne Myong, Director | ||
| Timothy Mack, VP of Marketing and Bus. Devel. | ||
| Jennifer Olson, Vice President and Managing Director - Doctor Directed Consumer Channel | ||
| Stuart Hockridge, Vice President - Global Human Resources | ||
| Julie Tay, Vice President Managing Director - Asia Pacific | ||
| Thomas Prescott, CEO and President and Director | ||
| Yuval Shaked, Senior Vice President Managing Director - iTero Scanner and Services Business | ||
| Charles Larkin, Independent Chairman of the Board | ||
| Julie Coletti, Executive Officer | ||
| Roger George, VP of Legal and Corporate Affairs, General Counsel and Corporate Secretary |
Align Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Align Technology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0682 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 22.07 B | ||||
| Shares Outstanding | 75.25 M | ||||
| Shares Owned By Insiders | 6.53 % | ||||
| Shares Owned By Institutions | 88.03 % | ||||
| Number Of Shares Shorted | 1.41 M | ||||
| Price To Earning | 29.97 X |
Align Technology Investors Sentiment
The influence of Align Technology's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Align. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Align Technology's public news can be used to forecast risks associated with an investment in Align. The trend in average sentiment can be used to explain how an investor holding Align can time the market purely based on public headlines and social activities around Align Technology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Align Technology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Align Technology's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Align Technology's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Align Technology.
Align Technology Implied Volatility | 127.46 |
Align Technology's implied volatility exposes the market's sentiment of Align Technology stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Align Technology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Align Technology stock will not fluctuate a lot when Align Technology's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Align Technology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Align Technology's short interest history, or implied volatility extrapolated from Align Technology options trading.
Pair Trading with Align Technology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Align Technology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Align Technology will appreciate offsetting losses from the drop in the long position's value.Moving together with Align Stock
| 0.86 | ELMD | Electromed | PairCorr |
| 0.78 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
Moving against Align Stock
| 0.89 | IVP | Inspire Veterinary | PairCorr |
| 0.8 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.66 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
| 0.62 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
| 0.43 | AHG | Akso Health Group | PairCorr |
The ability to find closely correlated positions to Align Technology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Align Technology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Align Technology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Align Technology to buy it.
The correlation of Align Technology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Align Technology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Align Technology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Align Technology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Align Technology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Align Stock, please use our How to Invest in Align Technology guide.Note that the Align Technology information on this page should be used as a complementary analysis to other Align Technology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Align Stock analysis
When running Align Technology's price analysis, check to measure Align Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Align Technology is operating at the current time. Most of Align Technology's value examination focuses on studying past and present price action to predict the probability of Align Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Align Technology's price. Additionally, you may evaluate how the addition of Align Technology to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Align Technology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Align Technology. If investors know Align will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Align Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.06 | Earnings Share 5.8 | Revenue Per Share 50.536 | Quarterly Revenue Growth 0.061 | Return On Assets 0.0682 |
The market value of Align Technology is measured differently than its book value, which is the value of Align that is recorded on the company's balance sheet. Investors also form their own opinion of Align Technology's value that differs from its market value or its book value, called intrinsic value, which is Align Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Align Technology's market value can be influenced by many factors that don't directly affect Align Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Align Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Align Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Align Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.